Medsafe

THE INDIGESTION medication Zantac is back on pharmacy shelves after being recalled in 2019.

Medsafe group manager Chris James discusses the new pharmacy audit regime

Cabinet has agreed to change the rules to allow Medsafe to approve new medicines in less than 30 days if the product already has approval from two recognised overseas jurisdictions

Pfizer New Zealand and BioNTech announce Medsafe’s consent for JN.1-adapted COVID-19 vaccine and its availability from January 2025. The updated COVID-19 vaccine can be given to adults and children 6 months and older

Associate Health Minister David Seymour is welcoming Cabinet’s decision to enable medicines to be approved in less than 30 days if the product has approval from two recognised overseas jurisdictions

The indigestion medication Zantac is back on pharmacy shelves after being recalled in 2019

Medsafe group manager Chris James looks at ways the agency can improve efficiency with the medicines-approval process

Medsafe has approved the first electronic controlled-drugs register for use in New Zealand pharmacies, associate health minister David Seymour announced today

Associate Health Minister David Seymour says he welcomes Medsafe’s decision to approve an electronic controlled drug register for use in New Zealand pharmacies, allowing pharmacies to replace their physical paper-based register

Unannounced audits are (mostly) gone and will not be coming back, reports Jonathan Chilton-Towle